Casdin Capital, LLC Diversified Active

Location: New York, NY

CIK: 0001534261 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 16, 2020

Total Value: $2.233B (100.0% shares, 0.0% debt)

Holdings (45)

INVITAE CORP 17.5%
Value $392M Shares 9,033,943 Est. Cost $3884.53 Unrealized
BLFS BIOLIFE SOLUTIONS INC 7.6%
Value $169M Shares 5,840,107 Est. Cost $15.79 Unrealized +36.8%
RLAY RELAY THERAPEUTICS INC 7.3%
Value $162M Shares 3,808,894 Est. Cost $38.13 Unrealized 0.0%
BLUEPRINT MEDICINES CORP 6.4%
Value $144M Shares 1,550,000 Est. Cost $5615.52 Unrealized
FATE FATE THERAPEUTICS INC 5.5%
Value $122M Shares 3,050,000 Est. Cost $8.50 Unrealized +310.5%
MYOKARDIA INC 5.3%
Value $119M Shares 870,000 Est. Cost $39.07 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 4.0%
Value $90.27M Shares 620,000 Est. Cost $91.85 Unrealized +54.7%
TWST TWIST BIOSCIENCE CORP 3.4%
Value $75.97M Shares 1,000,000 Est. Cost $26.75 Unrealized +132.7%
SRPT SAREPTA THERAPEUTICS INC 3.3%
Value $74.43M Shares 530,000 Est. Cost $121.78 Unrealized +24.8%
AGIO AGIOS PHARMACEUTICALS INC 2.7%
Value $61.25M Shares 1,750,000 Est. Cost $48.18 Unrealized -9.0%
RVMD REVOLUTION MEDICINES INC 2.5%
Value $56.88M Shares 1,634,535 Est. Cost $27.72 Unrealized -0.1%
GENERATION BIO CO 2.2%
Value $49.8M Shares 1,611,214 Est. Cost $21.00 Unrealized
BLUEBIRD BIO INC 2.2%
Value $49.36M Shares 915,000 Est. Cost $21744.46 Unrealized
BURNING ROCK BIOTECH LTD 2.2%
Value $48.21M Shares 1,922,150 Est. Cost $26.82 Unrealized
DNLI DENALI THERAPEUTICS INC 2.1%
Value $46.94M Shares 1,310,000 Est. Cost $18.95 Unrealized +58.9%
CDXS CODEXIS INC 2.1%
Value $46.78M Shares 3,985,000 Est. Cost $13.94 Unrealized -10.7%
CDNA CAREDX INC 2.0%
Value $45.27M Shares 1,193,335 Est. Cost $24.07 Unrealized +40.3%
PACB PACIFIC BIOSCIENCES CALIF IN 2.0%
Value $44.41M Shares 4,500,000 Est. Cost $5.76 Unrealized 0.0%
ONC BEIGENE LTD 1.9%
Value $42.97M Shares 150,000 Est. Cost $188.40 Unrealized
ALLO ALLOGENE THERAPEUTICS INC 1.6%
Value $35.64M Shares 945,000 Est. Cost $30.15 Unrealized +25.0%
ADPT ADAPTIVE BIOTECHNOLOGIES COR 1.6%
Value $34.68M Shares 713,125 Est. Cost $37.47 Unrealized +12.2%
ADVERUM BIOTECHNOLOGIES INC 1.3%
Value $28.32M Shares 2,750,000 Est. Cost $12.93 Unrealized
MAGENTA THERAPEUTICS INC 1.0%
Value $22.75M Shares 3,346,034 Est. Cost $1663.66 Unrealized
CRSP CRISPR THERAPEUTICS AG 1.0%
Value $22.28M Shares 266,430 Est. Cost $51.63 Unrealized +71.8%
GLOBAL BLOOD THERAPEUTICS IN 1.0%
Value $21.78M Shares 395,000 Est. Cost $37.90 Unrealized
AMYRIS INC 1.0%
Value $21.58M Shares 7,390,000 Est. Cost $3.90 Unrealized
CONSTELLATION PHARMCETICLS I 0.9%
Value $19.86M Shares 980,000 Est. Cost $6.31 Unrealized
TSHA TAYSHA GENE THERAPIES INC 0.8%
Value $18.38M Shares 820,440 Est. Cost $23.52 Unrealized 0.0%
ALEC ALECTOR INC 0.8%
Value $17.38M Shares 1,650,000 Est. Cost $17.70 Unrealized -8.6%
DMTKQ DERMTECH INC 0.8%
Value $17.07M Shares 1,428,572 Est. Cost $11.88 Unrealized
ZLAB ZAI LAB LTD 0.7%
Value $15.8M Shares 190,000 Est. Cost $51.48 Unrealized
BERKELEY LTS INC 0.7%
Value $15.27M Shares 200,000 Est. Cost $76.36 Unrealized
BRISTOL-MYERS SQUIBB CO 0.6%
Value $14.06M Shares 6,250,000 Est. Cost $2.78 Unrealized
FULC FULCRUM THERAPEUTICS INC 0.5%
Value $11.43M Shares 1,441,176 Est. Cost $11.41 Unrealized +5.5%
SGMO SANGAMO THERAPEUTICS INC 0.5%
Value $10.21M Shares 1,080,000 Est. Cost $8.80 Unrealized +23.0%
IOVA IOVANCE BIOTHERAPEUTICS INC 0.4%
Value $9.547M Shares 290,000 Est. Cost $30.66 Unrealized 0.0%
ILMN ILLUMINA INC 0.4%
Value $9.272M Shares 30,000 Est. Cost $196.93 Unrealized +75.0%
BDTX BLACK DIAMOND THERAPEUTICS I 0.4%
Value $8.748M Shares 289,395 Est. Cost $30.22 Unrealized +0.7%
ORCHARD THERAPEUTICS PLC 0.3%
Value $7.686M Shares 1,870,000 Est. Cost $2089.27 Unrealized
DYN DYNE THERAPEUTICS INC 0.3%
Value $7.47M Shares 370,000 Est. Cost $21.96 Unrealized 0.0%
TURNING POINT THERAPEUTICS I 0.3%
Value $6.552M Shares 75,000 Est. Cost $40080.00 Unrealized
ORIC ORIC PHARMACEUTICALS INC 0.3%
Value $6.29M Shares 251,515 Est. Cost $31.92 Unrealized -25.4%
LEGN LEGEND BIOTECH CORP 0.2%
Value $4.311M Shares 139,661 Est. Cost $42.17 Unrealized
STOK STOKE THERAPEUTICS INC 0.2%
Value $4.019M Shares 120,000 Est. Cost $27.21 Unrealized +4.9%
DECIPHERA PHARMACEUTICALS IN 0.1%
Value $3.335M Shares 65,000 Est. Cost $13347.64 Unrealized